Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT04181853 Completed - Clinical trials for Diabetes Mellitus, Type 2

The Effect of Aerobic Exercise on Genetic Molecules

xnx
Start date: February 5, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on some genetic molecules in patients with type 2 diabetes mellitus.

NCT ID: NCT04181307 Completed - Diabetes Clinical Trials

A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This RCT will test a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module incorporates effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely (CW) guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin. The implementation of the module is triggered by patient scheduling and medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior.

NCT ID: NCT04180332 Completed - Diabetes Mellitus Clinical Trials

Anti Oxidant Enzymes and Total Antioxidant Levels in Diabetes Mellitus Type II Patients and Healthy Individuals With Periodontitis

Start date: August 10, 2017
Phase: N/A
Study type: Interventional

To evaluate the role of antioxidants - superoxide dismutase, catalase, glutathione and total anti oxidant levels in the serum of chronic periodontitis patients and chronic periodontitis with DM Type II patients, then to compare it with healthy controls, to assess their possible role as biomarkers for chronic periodontitis and the possible systemic effects of periodontitis.

NCT ID: NCT04177147 Completed - Diabetes Mellitus Clinical Trials

Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care

HG_Tool
Start date: January 14, 2016
Phase: N/A
Study type: Interventional

Hypoglycemia (HG) is common and can be dangerous in diabetes mellitus, so identifying patients at risk may lead to useful preventive strategies and improved quality of care and health outcomes. This study will test the implementation of a computerized alert tool for clinicians.

NCT ID: NCT04172337 Completed - Obesity Clinical Trials

Testing the Effects of Singapore's Front-of-Pack Healthier Choice Symbol Label With or Without a Physical Activity Equivalent Label

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Poor diets are known risk factors for chronic diseases, and in recent years, food labelling has been increasingly sought-after as a cost-effective intervention to help stem the rising trend in chronic diseases. In efforts to promote a healthy diet, the Singapore Health Promotion Board (HPB) supplements traditional nutrition labelling with the Healthier Choice Symbol (HCS), which identifies food items within a specific category of foods as healthier choices. The original logos were enhanced to include additional information focusing on particular macronutrients, taking one of two themes; it either indicates that a product contains more of a healthier ingredient, or less of a less healthy ingredient. However, to date, no published studies have assessed the role of the original and enhanced HCS logos in influencing food choices. There is a lack of scientific evidence on the role of the existing symbols in assisting consumers make healthier food purchasing decisions. There are also concerns over the unintended consequences of health claims made based on a single aspect of nutrient content, without considering other aspects. That is the goal of this effort. Specifically, the investigators propose to conduct the following: Use a three arm randomized controlled trial (RCT) and an experimental fully functional web-based grocery store to assess the causal effect of the new HCS logos on measures of diet quality either alone, or in combination with a complementary front-of-package (FOP) label: Physical Activity Equivalents (PAEs), which provides information on how long one would need to engage in a certain activity (e.g., jogging) to burn off one serving of the product. The investigators hypothesize that the greatest reduction in calories per serving (primary outcome) will occur in the HCS plus PAEs arm, followed by HCS only, and no logo control arm.

NCT ID: NCT04168541 Completed - Clinical trials for Diabetes Mellitus, Type 2

Glycemic Response in Persons With Type 2 Diabetes Mellitus

Start date: February 5, 2018
Phase: N/A
Study type: Interventional

This will be a randomized crossover design. The subjects will be randomized to one of six interventions on six separate study days, one week apart.

NCT ID: NCT04166760 Completed - Clinical trials for Diabetes Mellitus, Type 2

Metabolic Effects of Whey Compounds in Patients With Diabetes Mellitus Type 2.

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

The main objective of our study is to investigate the metabolic effects of a i) ordinary whey protein (WHE) and ii) a specific whey protein fraction (speWHE) when the interventions are ingested by patients with type 2 diabetes 30 minutes prior to an oral glucose tolerance test (OGTT). We will also investigate the glucose response when the patients ingest the interventions at home in their own environment 30 minutes before breakfast and dinner (2days) and also monitor glucose levels without interventions (2 days).

NCT ID: NCT04161976 Completed - Clinical trials for Diabetes Mellitus, Type 1

A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus

Start date: December 27, 2019
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to learn more about a new formulation of insulin lispro when given by an insulin pump to participants with type 1 diabetes mellitus. The study will investigate how the body processes the drug and how the drug affects the body. Information about side effects will be collected. The study will last from six to 12 weeks for each participant.

NCT ID: NCT04161859 Completed - Hypertension Clinical Trials

Use of Nutraceuticals in Clinical Practice

Start date: May 1, 2017
Phase:
Study type: Observational

The aim of this study will be to evaluate the use of the nutraceutical with cardio-metabolic actions in clinical practice in addition to a Mediterranean diet scheme, normally recommended in the clinic. In particular the study will analyze how much the nutraceutical is prescribed and what are the purposes for which it is used and at what dosages.

NCT ID: NCT04161846 Completed - Clinical trials for Diabetes Mellitus Risk

Virtual World Training for Community Health Workers (CHW)

Start date: August 8, 2019
Phase: N/A
Study type: Interventional

Standard, effective, and scalable training models are needed to help equip community health workers in their community-based diabetes prevention awareness efforts. This study will tailor/adapt, implement, and evaluate an innovative internet-based virtual world model to remotely deliver a diabetes prevention awareness training program to community health workers.